Product acceptance in the health-care environment
8th August 2018

Technology innovators in the health-care sector can benefit from the research and expertise of the Oxford Clinical Allied Technology and Trials Services Unit (OxCATTS)

If you are a start-up company, you may often get lost in the processes required to have a product or idea accepted within the healthcare environment. In the current transition phase from European Medical Device Directives to European Medical Device Regulations some processes and requirements may be hard to navigate alone. A clinical trial unit (CTU) can help to ensure that the research meets these requirements and support in the design, conduct, analysis, and report of the study. Focussing on research in technology innovation (including traditional trials, innovative designs and clinical audits) aligns with Government and LEP strategies. The Government have identified key Grand Challenges for global strength and importantly targeted local strengths that include AI and High Performance Computing, the local UK Biobank, and interaction between genes and environment. There is also a strategy to develop further key capabilities, emerging technologies and distinctive advantages from cybersecurity. A key aim is to harness and the power of innovation to meet the needs of the ageing society including technologies, services, and products to help older citizens lead independent, fulfilled lives.  Local, national, and international technology innovation can be supported by experienced, high-quality, research-active, and professional services staff at all career levels through smaller, flexible operational models which can create more research opportunities and keep down costs. The OxCATTS team are happy to discuss trial and service needs in a friendly and flexible environment.

About the author

Helen
Dawes
Oxford Brookes University
Helen Dawes leads an interdisciplinary research team at Oxford Brookes University with an extensive track record on the development and translation of health-related research.

Latest news

For success in product development – start at square zero

For success in product development – start at square zero

When it comes to the commercial success of a technology-led product, there are a number of factors that come into play along the development journey. Have the regulatory requirements been met? Can the design be produced at a viable cost? Is it possible to ensure the quality of the manufacturing process? The list goes on. READ MORE

The not-so-small matter of scale: Making it big in microfluidics

The not-so-small matter of scale: Making it big in microfluidics

Microfluidics is a key technology enabling the development of rapid in-vitro diagnostics (IVD). With applications including COVID-19 testing, cardiac arrest assessment and STD screening, decentralised rapid diagnostics are shaping up to be a major part of the future of healthcare and wellness monitoring. READ MORE

R&D Tax Relief Schemes Update

R&D Tax Relief Schemes Update

Given the recent wide-ranging consultation on R&D tax relief, it was probably inevitable that reform of the R&D tax relief schemes (now over 20 years old) would be announced in the Chancellor’s Budget on 27 October 2021, although these announcements were headline only with more details to follow. READ MORE

 

PARTNERS

Visit Britain

Keep in touch

Sign up to the Venturefest Oxford newsletter to make sure you are the first to hear the latest news. The next #vfestox newsletter will be coming out soon! Make sure you're on the list!

 

 

 

 

 

Email Preferences

Venturefest Oxford will be returning on Thursday 25th November 2021

Make connections that lead to new investments, new businesses and new ideas in the high-tech sector in Oxfordshire.